PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer.
about
Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic StrategiesTumor-Associated Macrophages and Neutrophils in Tumor MicroenvironmentThe interaction of anticancer therapies with tumor-associated macrophagesThe Immune System in Tissue Environments Regaining Homeostasis after Injury: Is "Inflammation" Always Inflammation?Complement System Part II: Role in ImmunityFluid phase recognition molecules in neutrophil-dependent immune responses.The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodellingPTX3, a humoral pattern recognition molecule at the interface between microbe and matrix recognition.The Dual Complexity of PTX3 in Health and Disease: A Balancing Act?Inflammatory Long Pentraxin 3 is Associated with Leukocyte Telomere Length in Night-Shift Workers.Pentraxin 3 innately preps damaged tissue for wound healing.Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer.Simultaneous analysis of miRNA-mRNA in human meningiomas by integrating transcriptome: A relationship between PTX3 and miR-29c.C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation.Knockdown of Pentraxin 3 suppresses tumorigenicity and metastasis of human cervical cancer cells.Complement-Mediated Regulation of Metabolism and Basic Cellular ProcessesInhibitory Role of Pentraxin-3 in Esophageal Squamous Cell CarcinomaDriver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera.Upregulation of brain-derived neurotrophic factor in advanced gastric cancer contributes to bone metastatic osteolysis by inducing long pentraxin 3.Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation.Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial.Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients.Tumor-associated macrophages and anti-tumor therapies: complex links.Emerging prognostic markers related to mesenchymal characteristics of poorly differentiated breast cancers.Humoral innate immunity at the crossroad between microbe and matrix recognition: The role of PTX3 in tissue damage.Axl and Mer Receptor Tyrosine Kinases: Distinct and Nonoverlapping Roles in Inflammation and Cancer?Innate immune mediators in cancer: between defense and resistance.Complement in removal of the dead - balancing inflammation.Pentraxins in the activation and regulation of innate immunity.Innate immunity, hemostasis and matrix remodeling: PTX3 as a link.Complement factor H in host defense and immune evasion.The role of the complement system in cancer.Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury.Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy.Oleate-induced PTX3 promotes head and neck squamous cell carcinoma metastasis through the up-regulation of vimentin.A Commentary on "PTX3 is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer"Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer.High-Fat Diet-Induced Complement Activation Mediates Intestinal Inflammation and Neoplasia, Independent of Obesity.Hypoxia-inducible factors: a central link between inflammation and cancer.Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers.
P2860
Q26765342-62553F42-964E-4004-9207-0E0F5579D7BCQ26766429-3A4E6EB6-ABD0-44B7-8415-9BD18C9CE596Q27016634-CE39085C-4401-4D5D-B907-A11998D32D0DQ28066426-4F560CE4-B295-4CE0-ABA7-D41B43952576Q28263460-AA20D59B-1C65-4614-94B6-108E7C974A42Q33626308-A7D3DCA7-ACF2-4EF4-99DF-CC724203EF78Q33632041-F28A2B78-B271-47D9-8BFA-A93C0C510E84Q33632044-EFA8B84F-2A81-4E4D-9D43-C9705BF28D1AQ33632047-FEA54353-C467-4429-9FF5-A07CC57053B4Q33650222-0CBAD2AD-0E48-416A-9753-DB5E0991AB75Q35671255-B7864862-FC9B-4280-BC53-874DB9A15760Q35918276-0C69E416-9B27-4209-A179-FC2C09267234Q36317542-5BE3CCB6-9D0A-40BC-9A17-09398F039919Q36541076-F3A5C138-E287-4BAD-A751-2AF12B99793AQ37063998-BFE7B5B3-E820-455C-AF64-9021C8CA1EB1Q37248499-47AEE1B0-2093-4865-B63E-E3EA84DA5081Q37255030-2726D5E6-83E1-4C77-B502-D8F352D71F9AQ37661411-0B57867E-10D6-499B-97F7-B37F64A7F672Q37688261-42F4E801-DEF5-48D8-B6CB-773BF6575E81Q37696092-4E254262-FFE4-436F-8CEF-EE07C7C339D1Q38380295-AB27530C-9378-430D-BBB2-25D124798E16Q38386941-0FCD0D5B-EBFF-4502-B8FE-EB2DB778B163Q38766176-DD8BC37A-46F5-47FD-B3F1-F4D8DAF993ECQ38819847-6747BF12-A212-484C-AE17-A87A9FB514DEQ38914027-361FF763-B96D-442C-9A9B-781E3E76DBB4Q38936702-9921B30B-0DE7-43DB-B150-695ED7B4D91BQ38991015-F3AD1D2D-50FE-4BFF-B0D6-B8B7C924973AQ38991044-EA5674D7-6598-4135-BD56-ABA81527B90DQ38991073-347FE53C-E2D0-4807-A88B-51232E882F69Q39018377-2B7BD0AC-50F6-4C04-8111-977A5CBF4A31Q39036058-65AE376A-8278-44BE-AFF4-071D72615A4BQ39156024-60A13EA4-45EA-4843-BA50-8509415DC0D0Q40245731-76112EEE-EA30-463E-89EA-2B7C826D304BQ41068034-69D4BC0C-9FFA-4A03-9492-84ADB68EAF57Q41093646-434D7402-48DE-4441-9AC3-FE2594FE1F37Q41226854-C5E9DC24-AB70-4DE0-A5A8-3E576EECBF01Q41252240-F16D4C94-E66F-45D1-8BBC-F2EEF395498DQ41653522-91C0D5BC-5F41-4857-8CF1-980E487AB6E4Q41678975-4861F4B3-3901-49E4-80BF-5F6F49ACA10FQ42505998-68998B41-125A-417E-B675-05E3595B4D6B
P2860
PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
PTX3 is an extrinsic oncosuppr ...... endent inflammation in cancer.
@ast
PTX3 is an extrinsic oncosuppr ...... endent inflammation in cancer.
@en
PTX3 is an extrinsic oncosuppr ...... endent inflammation in cancer.
@nl
type
label
PTX3 is an extrinsic oncosuppr ...... endent inflammation in cancer.
@ast
PTX3 is an extrinsic oncosuppr ...... endent inflammation in cancer.
@en
PTX3 is an extrinsic oncosuppr ...... endent inflammation in cancer.
@nl
prefLabel
PTX3 is an extrinsic oncosuppr ...... endent inflammation in cancer.
@ast
PTX3 is an extrinsic oncosuppr ...... endent inflammation in cancer.
@en
PTX3 is an extrinsic oncosuppr ...... endent inflammation in cancer.
@nl
P2093
P50
P1433
P1476
PTX3 is an extrinsic oncosuppr ...... endent inflammation in cancer.
@en
P2093
Elisa Barbati
Fabio Pasqualini
Francesca Feruglio
Gianluca Basso
Ilaria Laface
Marcello Rubino
Martina Molgora
Piergiuseppe Colombo
Silvia Tartari
Stefania Gentile
P304
P356
10.1016/J.CELL.2015.01.004
P407
P50
P577
2015-02-01T00:00:00Z